NeuroMetrix, Inc. (NASDAQ:NURO) today announced the launch of LivingQuell, a blog that will serve as an online resource for people affected by chronic pain – as well as the rapidly growing user base of the company’s Quell(R) Wearable Pain Relief Technology(TM).
The EPS of $(0.91) that NeuroMetrix Inc. (NASDAQ:NURO) reported in the latest quarter came from sales of 4.31M%. Sales increased 89.30% from the prior quarter.
To generate 4.31M% in sales, the company invested $2.7M, with that being the cost of goods sold. Its gross margin for the quarter came to $1.61M after deducting the cost of goods sold from the sales figure.
Let?s look into the charts of the stock
The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction. Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.
Can NeuroMetrix Inc. fund its operations in the foreseeable future? The company finished the latest quarter with cash balance of 6.9M%. It generated free cash flow of $(3.35M) in the quarter, with operating activities producing $(3.35M) in net cash flow.
NeuroMetrix Inc.’s total assets at the end of the latest quarter were $11.09M, while total liabilities were $3.24M.
Analysts on the average have a recommendation of 2.00 on the stock NeuroMetrix Inc.. In deciphering the analyst recommendation, investors should keep in mind that a recommendation of 1 signifies BUY, 3 indicates HOLD and 5 implies SELL.
As for the price target, analysts are expecting the stock to hit $28.00 by the end of the next 12 months. Considering the stock?s prevailing price of $4.00, you can see what analyst expect to happen to the price down the line.
To trade at the current price of $4.00, the stock has over the last 12 months traded in the range of a low of $949.32% and a high of $-11.11%.